HUP9802915A2 - Új sztafilokinázszármazékok - Google Patents

Új sztafilokinázszármazékok

Info

Publication number
HUP9802915A2
HUP9802915A2 HU9802915A HUP9802915A HUP9802915A2 HU P9802915 A2 HUP9802915 A2 HU P9802915A2 HU 9802915 A HU9802915 A HU 9802915A HU P9802915 A HUP9802915 A HU P9802915A HU P9802915 A2 HUP9802915 A2 HU P9802915A2
Authority
HU
Hungary
Prior art keywords
dna fragment
directed mutagenesis
plasmid
strain
host cell
Prior art date
Application number
HU9802915A
Other languages
English (en)
Inventor
Desiré José Collen
Original Assignee
Leuven Research & Development Vyw
Desiré José Collen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP95200023A external-priority patent/EP0721982A1/en
Priority claimed from EP95201531A external-priority patent/EP0721013B1/en
Application filed by Leuven Research & Development Vyw, Desiré José Collen filed Critical Leuven Research & Development Vyw
Publication of HUP9802915A2 publication Critical patent/HUP9802915A2/hu
Publication of HUP9802915A3 publication Critical patent/HUP9802915A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány tárgya eljárás sztafilőkinázszármazékők előállítására,amely abban áll, hőgy előállítanak egy DNS-fragmenst, amely asztafilőkinázt kódőló szekvenciának legalább a biőlógiai aktivitásértfelelő részét tartalmazza; in vitrő helyre irányítőtt műtagenezisthajtanak végre a DNS-fragmensen, hőgy a vad-típűsban egy vagy többaminősavat kódőló kődőnt egy másik aminősavat kódőló kődőnrakicseréljenek; a műtált DNS-fragmenst egy alkalmas vektőrba klónőzzák;a vektőrral egy alkalmas gazdasejtet transzfőrmálnak vagytranszfektálnak; és a gazdasejtet megfelelő körülmények közötttenyésztve a DNS-fragmenst kifejezik. Előnyösen a DNS-fragmens apMEX602SAK plazmid egy 453 bp EcőRI-HindIII fragmense, az in vitrőhelyre irányítőtt műtagenezist egy őligőnűkleőtid-irányítőttműtagenezis-rendszerrel végzik felhasználva a pMa/c plazmidőt és ajavítórendszer-deficiens E. cőli WK6MűtS törzset, a műtált DNS-fragmenst az E. cőli WK6 törzsben expresszálják. A találmány tővábbáartériás trőmbózis kezelésére szőlgáló gyógyászati készítményekre isvőnatkőzik, melyek legalább egy találmány szerintisztafilőkinázszármazékőt tartalmaznak egy alkalmas hőrdőzóval együtt. ŕ
HU9802915A 1995-01-06 1996-01-03 New staphylokinase derivatives HUP9802915A3 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP95200023A EP0721982A1 (en) 1995-01-06 1995-01-06 New staphylokinase derivatives
US08/371,505 US5695754A (en) 1995-01-06 1995-01-11 Staphylokinase derivatives
EP95201531A EP0721013B1 (en) 1995-01-06 1995-06-09 New staphylokinase derivatives
US49909295A 1995-07-06 1995-07-06
JP7299781A JPH08289790A (ja) 1995-01-06 1995-11-17 新規なスタフィロキナーゼ誘導体

Publications (2)

Publication Number Publication Date
HUP9802915A2 true HUP9802915A2 (hu) 1999-03-29
HUP9802915A3 HUP9802915A3 (en) 2001-02-28

Family

ID=27514236

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9802915A HUP9802915A3 (en) 1995-01-06 1996-01-03 New staphylokinase derivatives

Country Status (22)

Country Link
EP (1) EP0793723B1 (hu)
JP (1) JPH08289790A (hu)
CN (1) CN1154729C (hu)
AT (1) ATE306550T1 (hu)
AU (1) AU705119B2 (hu)
BG (1) BG64344B1 (hu)
BR (1) BR9606724A (hu)
CA (1) CA2206479A1 (hu)
CZ (1) CZ290685B6 (hu)
DE (1) DE69635269T2 (hu)
EA (1) EA000121B1 (hu)
EE (1) EE9700150A (hu)
ES (1) ES2248805T3 (hu)
FI (1) FI972862A (hu)
HU (1) HUP9802915A3 (hu)
NO (1) NO973083L (hu)
NZ (1) NZ298801A (hu)
PL (1) PL184348B1 (hu)
RO (1) RO116969B1 (hu)
SK (1) SK89297A3 (hu)
TR (1) TR199700600T1 (hu)
WO (1) WO1996021016A2 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5951980A (en) * 1995-01-06 1999-09-14 Leuven Research & Development Vzw Identification, production and use of new staphylokinase derivatives with reduced immunogenicity
JP2003500003A (ja) * 1998-10-30 2003-01-07 ノボザイムス アクティーゼルスカブ 低いアレルゲン性のタンパク質変異型
US6686164B1 (en) 1998-10-30 2004-02-03 Novozymes A/S Low allergenic protein variants
CN100342007C (zh) * 2000-01-28 2007-10-10 复旦大学 一种新型重组葡激酶及其制备方法
US6673580B2 (en) 2000-10-27 2004-01-06 Genentech, Inc. Identification and modification of immunodominant epitopes in polypeptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0621899B1 (de) * 1991-12-30 1996-06-19 Medac Gesellschaft für klinische Spezialpräparate mbH Expression signalpeptid-freier staphylokinasen

Also Published As

Publication number Publication date
DE69635269D1 (de) 2006-02-23
EP0793723A2 (en) 1997-09-10
EP0793723B1 (en) 2005-10-12
BG101556A (en) 1998-02-27
AU705119B2 (en) 1999-05-13
RO116969B1 (ro) 2001-08-30
BG64344B1 (bg) 2004-10-29
CN1168156A (zh) 1997-12-17
WO1996021016A2 (en) 1996-07-11
HUP9802915A3 (en) 2001-02-28
EA199700073A1 (ru) 1997-12-30
FI972862A (fi) 1997-09-03
ATE306550T1 (de) 2005-10-15
PL184348B1 (pl) 2002-10-31
MX9705041A (es) 1998-07-31
JPH08289790A (ja) 1996-11-05
BR9606724A (pt) 1998-01-13
CN1154729C (zh) 2004-06-23
NO973083L (no) 1997-08-04
NZ298801A (en) 2000-01-28
SK89297A3 (en) 1998-05-06
PL321181A1 (en) 1997-11-24
DE69635269T2 (de) 2006-06-14
EE9700150A (et) 1997-12-15
CA2206479A1 (en) 1996-07-11
AU4437796A (en) 1996-07-24
CZ290685B6 (cs) 2002-09-11
FI972862A0 (fi) 1997-07-04
TR199700600T1 (xx) 1998-01-21
WO1996021016A3 (en) 1996-09-12
EA000121B1 (ru) 1998-08-27
CZ210497A3 (en) 1997-11-12
NO973083D0 (no) 1997-07-02
ES2248805T3 (es) 2006-03-16

Similar Documents

Publication Publication Date Title
ATE77104T1 (de) Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute.
CA2171759A1 (en) Methods and compositions for high protein production from recombinant dna
AU649640B2 (en) A method of preparing a plasmid, the plasmid and expression products thereof
HUP9802915A2 (hu) Új sztafilokinázszármazékok
ES2090036T3 (es) Metodo para producir acido clavulanico.
CA2088068A1 (en) Protein structure of the plant toxin gelonin
WO1999040198A3 (en) Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance
AU3475495A (en) Process for producing recombinant proteins, plasmids and modified cells
FI924909A (fi) Biosyntetiskt foerfarande foer framstaellning av kemiska foereningar
DE69027466T2 (de) Achromobacter-Protease-I-Gen sowie Genprodukt
IL82207A0 (en) Production of peptides,recombinant plasmid used therefor and animal cells transformed therewith
CA2102043A1 (en) Mutant aox2 promoter, vector carrying same, transformant, and production of heterologous protein
KR880010129A (ko) 외래유전자의 발현제어방법 및 그 방법을 사용한 외래유전자 산물의 생산방법
EP0422217A4 (en) Human recombinant placental ribonuclease inhibitor and method of production
EP0300425A3 (de) Verfahren zur Herstellung von Proteinen in löslicher Form
AU4590889A (en) Protease, reverse transcriptase and endonuclease of petrovirus, and method for producing these enzymes
DE69737007D1 (de) Protein-disulfidisomerase-Gen eines methylotrophen Hefestammes
ATE292678T1 (de) Klonierung und rekombinante herstellung von polistinae venom-enzymen, beispielsweise phospholipase und hyaluronidase, und immunologische therapien davon abgeleitet
DK0592574T3 (da) Fremgangsmåde til fremstilling af rekombinante proteiner og værtsceller anvendt derved